Docstoc

Global API Market (Active Pharmaceutical Ingredients) Reports to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand

Document Sample
Global API Market (Active Pharmaceutical Ingredients) Reports to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand Powered By Docstoc
					RnR Market Research Offers “Active Pharmaceutical Ingredients (API) Global Market to 2017
– Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising
Domestic Demand” Report at US$ 3500 (Single User License). The report got published in
Nov 2012 and contains 221 Pages.




Active Pharmaceutical Ingredients (API) Global Market to 2017 – Growth in Developing Markets to Come
From Cost Efficient Manufacturing and Rising Domestic Demand

Summary

GBI Research’s report, “Active Pharmaceutical Ingredients (API) Global Market to 2017 – Growth in
Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand” provides
detailed insight into the global APIs market. The research presents detailed analysis and forecasts of the
major economic and market trends affecting the global APIs market. The report contains market forecasts,
product type analysis, and drivers and restraints for growth. In addition, it includes therapeutic category
analysis and contract manufacturing organizations’ (CMO) growth in the region, and their influence on API
manufacturing activity towards 2017. Overall, the report presents a comprehensive analysis of the global APIs
market, covering all the major parameters. The report is built using data and information sourced from
proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of
industry experts.

The global APIs market was dominated by North America, which generated 35.1% of global API revenues in
2011. The Asia-Pacific region also saw high growth, second behind North America with a revenue share of
29.7% in 2011.

The global APIs market revenues reached $108,613m in 2011. In the product-based segments, the synthetic
market dominated the market with 82.7% of global APIs revenues.

However, increasing acceptance and increasing penetration are boosting the biopharmaceuticals drug market
in both developed and developing economies.

Scope

       Market revenue data for APIs from 2005 to 2011, forecast forward for six years to 2017.
        API markets in the regions of North America, Asia-Pacific and Europe, along with key countries such
        as the US, Canada, Japan, China, South Korea, India, Italy, Germany, France, the UK and Spain.
       API industry structure and market trends, such as a shift in manufacturing and growth in
        biotechnology globally.
       Drivers and restraints for the global APIs market.
       Detailed historical, forecast trend and share analysis of API revenues based on product types
        (synthetic and biotechnology APIs) at the global, regional and key country levels.
       Detailed historical and forecast trends and share analysis for API revenues based on the customer
        base (generic and innovative for synthetic APIs, biosimilars and biologics for biotech APIs) at the
        global, regional and key country levels.
       Analysis of API revenues based on therapeutic categories at a global and regional level.

Buy your copy of this report @ http://www.rnrmarketresearch.com/active-pharmaceutical-ingredients-
api-global-market-to-2017-growth-in-developing-markets-to-come-from-cost-efficient-manufacturing-
and-rising-domestic-demand-market-report.html

Reasons to buy

      Develop business strategies with the help with specific insights in the global API market.
      Identify opportunities and challenges in the global API market.
      Invest in the growing segments of the APIs market.
      Increase future revenue and profitability with the help of insights into the future opportunities and
       critical success factors in the global APIs market.
      Benchmark your operations and strategies against the major players in the global APIs market.

Table of Contents

1 Table of Contents 6
1.1 List of Tables 10
1.2 List of Figures 12
2 Introduction 15
3 Global Active Pharmaceutical Ingredients Market 16
3.1 Global API Market Overview 16
3.2 Global API Market Drivers 16
3.2.1 Patent Expiries to Change the Dynamics of the Global API Market 16
3.2.2 Increased Uptake of Biologics Across Different Therapeutic Areas and Government Initiatives for
Biomedical Research Set to Boost API Revenues 16
3.2.3 Increased Mergers and Acquisitions to Drive Global Pharmaceutical Industry Growth 16
3.2.4 Increasing Geographical Penetration and Elderly Population to Drive Growth of the Global
Pharmaceutical and API Markets 16
3.2.5 Patent Expiries of Major Drugs to Support Pharmaceutical Market Revenue Growth in Underpenetrated
Markets 17
3.3 Global API Market Restraints 17
3.3.1 Economic Recession to Restrict Investment in the Pharmaceutical Industry 17
3.3.2 Limited Improvement in Pharmaceutical Manufacturing Capabilities May Reduce Overall Growth
Potential 17
3.3.3 Increasing Patent Expiries to Impede Growth of the Global API Market 17
3.3.4 Regulatory Changes to Delay the Launch of New Drugs 18
3.4 Global API Market Revenue Analysis and Forecast to 2017 19
3.4.1 Global API Market Revenue Share by Product Type 21
3.4.2 Global Synthetic Market Revenue Analysis and Forecast to 2017 22
3.4.3 Global Synthetic Market Revenue Share Analysis by Customer Base 26
3.4.4 Global Synthetic Market Revenue Analysis and Forecast to 2017 27
3.5 Global Biotech Market Analysis 29
3.5.1 Global Biotech Market Revenue Analysis and Forecast to 2017 29
3.6 Global Biotech Market Revenue Analysis by Customer Base 34
3.6.1 Global Biotech Market Revenue Share Analysis by Customer Base 34
3.6.2 Global Biotech Market Revenue Analysis and Forecast to 2017 35
3.7 Global Contract Manufacturing Organizations 37
3.7.1 Global CMO Outsourcing Process 38
3.7.2 Global CMO Market Drivers 39
3.7.3 Global CMO Market Outsourcing Benefits 40
3.7.4 Global CMO Market Revenues and Forecast to 2017 41
4 North America Active Pharmaceutical Ingredients Market 43
4.1 North America API Market Overview 43
4.2 North America API Market Drivers 43
4.2.1 Continuous Growth in the Pharmaceutical Industry to Sustain API Market Growth in North America 43
4.2.2 Generic Sector Supports the Growth of the North American API Market 43
4.2.3 Increasing Focus on Biological Drugs to Support API Market Revenue Growth 43
4.3 North American API Market Restraints 44
4.3.1 Recent Economic Slowdown has Restricted Pharmaceutical Industry Growth 44
4.3.2 High Cost of New Drug Development Hampers Innovation 44
4.3.3 Patent Expiries of Blockbuster Molecules to Contain API Market Growth in North America 44
4.4 North America API Market Revenue Analysis and Forecast to 2017 45
4.5 North America API Market Revenue Share Analysis by Product Type 47
4.6 North America Synthetic Market Analysis 48
4.6.1 North America Synthetic Market Revenue Analysis and Forecast to 2017 48
4.6.2 North America Synthetic Market Revenue Share Analysis by Customer Base 53
4.6.3 North America Synthetic Market Revenue Analysis by Customer Base and Forecast to 2017 54
4.7 North America Biotech Market Analysis 56
4.7.1 North America Biotech Market Revenue Analysis and Forecast to 2017 56
4.7.2 North America Biotech Market Revenue Share Analysis by Customer Base 61
4.7.3 North America Biotech Market Revenue Analysis by Customer Base and Forecast to 2017 62
4.8 North America API Market Revenue Share Analysis by Therapeutic Applications 64
4.9 The US Active Pharmaceutical Ingredients Market 65
4.9.1 The US API Market Overview 65
4.9.2 The US API Market Revenue by Product Type and Forecast to 2017 66
4.9.3 The US API Market Revenue Share Analysis by Product Type and Forecast to 2017 68
4.9.4 The US API Market by Customer Base 69
4.10 Canada Active Pharmaceutical Ingredients Market 75
4.10.1 Canada API Market Overview 75
4.10.2 Canada API Market Revenue Analysis by Product Type and Forecast to 2017 75
4.10.3 Canada API Market Revenue Share Analysis by Product Types and Forecast to 2017 77
4.10.4 Canada API Market by Customer Base 78
5 Asia-Pacific Active Pharmaceutical Ingredients Market 84
5.1 Asia-Pacific API Market Overview 84
5.2 Asia-Pacific APIs Market Drivers 85
5.2.1 Pharmaceutical Manufacturing Capabilities in Developing Countries such as China and India to Attract
API Manufacture 85
5.2.2 Domestic Market Growth of Developing Countries in Asia-Pacific to Drive Global Pharmaceutical
Industry Growth 85
5.2.3 Increasing Focus on Biotech API Drugs in Asia-Pacific will Contribute to Major Asia-Pacific API Market
Growth 85
5.2.4 Improving Regulatory Framework in China and India is Increasing Penetration for Branded Drugs 85
5.2.5 Patent Expiries of Blockbuster Drugs to Boost Market Revenues in Asia-Pacific Markets 85
5.3 Asia-Pacific API Market Restraints 86
5.3.1 Increasing Incidence of Patent Expiries to Hamper Growth for Branded API Market 86
5.3.2 Highly Fragmented Market to Restrict Revenue Growth for the Asia-Pacific API Market 86
5.3.3 Limited Improvement in Pharmaceutical Manufacturing Capabilities may Hamper Overall Growth
Potential 86
5.3.4 Currency Fluctuations to Hamper Value Growth of Pharmaceutical Market in Asia-Pacific Region 86
5.4 Asia-Pacific API Market Revenue and Forecasts to 2017 87
5.5 Asia-Pacific Revenue Share Analysis by Product Type 89
5.6 Asia-Pacific Synthetic Market 90
5.6.1 Asia-Pacific Synthetic Market Revenues and Forecast to 2017 90
5.6.2 Asia-Pacific Synthetic Market Revenue Share Analysis by Consumer Base 95
5.6.3 Asia-Pacific Synthetic Market Revenues by Customer Base and Forecast to 2017 96
5.7 Asia-Pacific Biotech Market 98
5.7.1 Asia-Pacific Biotech Market Revenues and Forecasts to 2017 98
5.7.2 Asia-Pacific Biotech Market Revenue Share Analysis by Customer Base 104
5.7.3 Asia-Pacific Biotech Market Revenue by Customer Base and Forecast to 2017 105
5.8 Asia-Pacific API Market Share Analysis by Therapeutic Applications 107
5.9 Japan Active Pharmaceutical Ingredients Market 108
5.9.1 Japan API Market Overview 108
5.9.2 Japan API Market Revenues and Forecasts to 2017 108
5.9.3 Japan API Market Revenue Share Analysis by Product Type 110
5.9.4 Japan API Market by Customer Base 111
5.10 China Active Pharmaceutical Ingredients Market 117
5.10.1 China API Market Overview 117
5.10.2 China API Market Revenues by Product Type and Forecasts to 2017 118
5.10.3 China API Market Revenue Share Analysis by Product Types 120
5.10.4 China API Market by Customer Base 121
5.11 South Korea Active Pharmaceutical Ingredients Market 127
5.11.1 South Korea API Market Overview 127
5.11.2 South Korea APIs Market Revenue and Forecasts to 2017 128
5.11.3 South Korea API Market Revenue Share Analysis by Product Type 130
5.11.4 South Korea API Market by Customer Base 131
5.12 India Active Pharmaceutical Ingredients Market 137
5.12.1 India API Market Overview 137
5.12.2 India API Market Revenue and Forecasts to 2017 138
5.12.3 India API Market Revenue Share Analysis by Product Types 140
5.12.4 India API Market by Customer Base 141
6 Europe Active Pharmaceutical Ingredients Market 147
6.1 Europe API Market Overview 147
6.2 Europe API Market Drivers 147
6.2.1 Increased CMO Opportunities Expected to Improve the Production of Generics and Drive API Revenue
Growth in Europe 147
6.2.2 Overall Growth in the Pharmaceutical Industry and Increasing Elderly Population to Drive the Growth for
the European API Market 147
6.2.3 Biopharmaceutical Therapies to Support API Market Growth in Europe 147
6.2.4 European Regulatory Framework to Facilitate Development of Biosimilars 147
6.2.5 Differences in VAT rates on Pharma Products to Increase Parallel Trade in Europe 147
6.3 Europe API Market Restraints 148
6.3.1 Increased Consumption of Generics to Limit the Premium Earned from Branded Products 148
6.3.2 Increasing Patent Expiries to Hamper the Growth of the European API Market 148
6.3.3 Price Cuts to Restrict Revenue Growth for the European API Market 149
6.4 Europe API Market Revenue Analysis and Forecast to 2017 151
6.5 Europe API Market Revenue Share Analysis by Product Type 153
6.6 Europe Synthetic Market Analysis 154
6.6.1 Europe Synthetic Market Revenue Analysis and Forecast to 2017 154
6.6.2 European Synthetic Market Revenue Share Analysis by Customer Base 159
6.6.3 Europe Synthetic Market Revenue by Customer Base and Forecast to 2017 160
6.7 Europe Biotech Market Analysis 162
6.7.1 Europe Biotech Market Revenue Analysis and Forecast to 2017 162
6.7.2 Europe Biotech Market Revenue Share Analysis by Customer Base 167
6.7.3 Europe Biotech Market Revenues by Customer Base and Forecast to 2017 168
6.8 Europe API Market Revenue Share Analysis by Therapeutic Applications 170
6.9 Germany Active Pharmaceutical Ingredients Market 172
6.9.1 Germany API Market Overview 172
6.9.2 Germany API Market Revenue Analysis by Product Type and Forecast to 2017 172
6.9.3 Germany API Market Revenue Share Analysis by Product Type and Forecast to 2017 174
6.9.4 Germany API Market by Customer Base 175
6.10 France Active Pharmaceutical Ingredients Market 181
6.10.1 France API Market Overview 181
6.10.2 France API Market Revenue Analysis by Product Type and Forecast to 2017 181
6.10.3 France API Revenue Share Analysis by Product Type and Forecast to 2017 183
6.10.4 France API Market by Customer Base 184
6.11 Italy Active Pharmaceutical Ingredients Market 190
6.11.1 Italy API Market Overview 190
6.11.2 Italy API Market Revenue Analysis by Product Type and Forecast to 2017 190
6.11.3 Italy API Market Revenue Share Analysis by Product Type and Forecast to 2017 192
6.11.4 Italy API Market by Customer Base 193
6.12 The UK Active Pharmaceutical Ingredients Market 199
6.12.1 The UK API Market Overview 199
6.12.2 The UK API Market Revenue Analysis by Product Type and Forecast to 2017 199
6.12.3 The UK API Market Revenue Share Analysis by Product Types and Forecast to 2017 201
6.12.4 The UK API Market by Customer Base 202
6.13 Spain Active Pharmaceutical Ingredients Market 208
6.13.1 Spain API Market Overview 208
6.13.2 Spain API Market Revenue Analysis by Product Type and Forecast to 2017 208
6.13.3 Spain API Market Revenue Share Analysis by Product Types and Forecast to 2017 210
6.13.4 Spain API Market by Customer Base 211
7 Appendix 217
7.1 Abbreviations 217
7.2 Bibliography 218
7.3 Market Definitions 219
7.4 Methodology 219
7.4.1 Coverage 219
7.4.2 Secondary Research 220
7.4.3 Primary Research 220
7.4.4 Expert Panel Validation 220
7.5 Contact Us 221
7.6 Disclaimer 221

For more details contact Mr. Priyank Tiwari: sales@rnrmarketresearch.com / +18883915441

Website: http://www.rnrmarketresearch.com/

				
DOCUMENT INFO
Description: “Active Pharmaceutical Ingredients (API) Global Market to 2017 – Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand” provides detailed insight into the global APIs market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the global APIs market. The report contains market forecasts, product type analysis, and drivers and restraints for growth.